Provencio M, Nadal E, Insa A, Garcia Campelo R, et al. Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial. Lancet Oncol 2024 Oct 14:S1470-2045(24)00498.
PMID: 39419061